Hospital-Acquired Pneumonia: Pathophysiology, Diagnosis, and Treatment

Surgical Clinics of North America

Volumn 89, Issue 2, 2009, Pages 439-461

  Kieninger, Alicia N ^a   Lipsett, Pamela A ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Anesthesiology   (United States)

Author keywords

Diagnosis; Epidemiology; Nosocomial infection; Pathophysiology; Pneumonia; Ventilator

Indexed keywords

AMINOGLYCOSIDE; ANTIHISTAMINIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; FLUCONAZOLE; LINEZOLID; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ALCOHOL CONSUMPTION; ANTIBIOTIC THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMA; ENDOTRACHEAL INTUBATION; ENDOTRACHEAL TUBE; ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HEALTH CARE; HEMODYNAMICS; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; HYGIENE; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE; LABORATORY TEST; LENGTH OF STAY; MALNUTRITION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NEUTROPENIA; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PNEUMONIA; PREVALENCE; PREVENTION AND CONTROL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RADIODIAGNOSIS; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME; UREMIA; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DECONTAMINATION; HUMANS; INCIDENCE; PNEUMONIA, BACTERIAL; RESPIRATION, ARTIFICIAL; RISK FACTORS;

EID: 61549095024     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2008.11.001     Document Type: Review

References (124)

1. American Thoracic Society. Guidelines for the management of adult with hospital-acquired, ventilator-associated and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 (2005) 388-416
2. Centers for Disease Control and Prevention (CDC). Guidelines for preventing health-care-associated pneumonia, 2003. MMWR Recomm Rep 53 (2004) 1-36
3. Warren D.K., Shukla S.J., Oslen M.A., et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 31 (2003) 1312-1317
4. Safdar N., Cameron D., Collard H.R., et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 33 (2005) 2184-2193
5. Sopena N., Sabrià M., et al. Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest 127 (2005) 213-219
6. Rello J. Bench to bedside review: therapeutic options and issues in the management of ventilator-associated bacterial pneumonia. Crit Care 9 (2005) 259-265
7. Rello J., Ollendorf D.A., Oster G., et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 122 (2002) 2115-2121
8. Berger M.M., Eggimann P., Heyland D.K., et al. Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomized trials. Crit Care 10 (2006) R153-R160
9. von Dossow V., Rotard K., Redlich U., et al. Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients. Crit Care 9 (2005) R662-R669
10. Metheny N.A., Clouse R.E., Chang Y., et al. Tracheobronchial aspiration in critically ill tube-fed patients: frequency, outcomes and risk factors. Crit Care Med 34 (2006) 1007-1015
11. Hunter J.P. Ventilator-associated pneumonia. Postgrad Med J 82 (2006) 172-178
12. Metheny N.A. Preventing respiratory complications of tube feedings: evidence-based practice. Am J Crit Care 15 (2006) 360-369
13. Drakulovic M.B., Torres A., Bauer T.T., et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomized trial. Lancet 354 (1999) 1851-1858
14. Howard L.S.G.E., Sillis M., Pasteur M.C., et al. Microbiological profile of community-acquired pneumonia in adults over the last 20 years. J Infect 50 (2005) 107-113
15. Chastre J. Antimicrobial treatment of hospital-acquired pneumonia. Infect Dis Clin North Am 17 (2003) 727-737
16. Park D.R. The microbiology of ventilator-associated pneumonia. Respir Care 50 (2005) 742-765
17. Dennesen P.J., van der Ven A.J., Kessels A.G., et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator associated pneumonia. Am J Respir Crit Care Med 163 (2001) 1371-1375
18. Sandiumenge A., Diaz E., Bodi M., et al. Therapy of ventilator-associated pneumonia: a patient-based approached based on the ten rules of the "Tarragona Strategy. Intensive Care Med 29 (2003) 876-883
19. Rupp M.E., and Fey P.D. Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteraciea: considerations for diagnosis, prevention and drug treatment. Drugs 63 (2003) 353-365
20. Colodner R. Extended-spectrum beta-lactamases: a challenge for clinical microbiologists and infection control specialists. Am J Infect Control 33 (2005) 104-107
21. Zavaski A.P., Barth A.L., Fernandes A.F., et al. Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia in the era of metallo-β-lactamase-mediated multidrug resistance: a prospective, observational study. Crit Care 10 (2006) R114-R120
22. Combes A., Luyt C., Fagon J., et al. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med 35 (2007) 146-154
23. Scott P., Deye G., Srinivasan A., et al. An outbreak of multidrug-resistant Acinetobacter baumannii-caloaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 44 (2007) 1577-1584
24. Maragakis L.L., and Perl T.M. Acinetobacter baumannii: epidemiology, antimicrobial resistance and treatment options. Clin Infect Dis 46 (2008) 1254-1263
25. Bonomo R.A., and Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 43 suppl 2 (2006) 49-56
26. Garnacho-Montero J., Ortiz-Leyba C., Fernandez-Hinojosa E., et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 31 (2005) 649-655
27. Goldman L., Caldera D.L., Nussbaum S.R., et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 297 (1977) 845-850
28. Brooks-Brunn J.A. Validation of a predictive model for postoperative pulmonary complications. Heart Lung 27 (1998) 151-158
29. Castillo R., and Haas A. Chest physical therapy: comparative efficacy of preoperative and postoperative in the elderly. Arch Phys Med Rehabil 66 (1985) 376-379
30. Epstein S.K., Faling L.J., Daly B.D., et al. Predicting complications after pulmonary resection: preoperative exercise testing versus a multifactorial cardiopulmonary risk index. Chest 104 (1993) 694-700
31. Arozullah A.M., Daley J., Henderson W.G., et al. Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery: the National Veterans Administration Surgical Quality Improvement Program. Ann Surg 232 (2000) 242-253
32. Johnson R.M., Arozullah A.M., Neumayer L., et al. Multivariable predictors of postoperative respiratory failure after general and vascular surgery: results from the Patient Safety in Surgery Study. J Am Coll Surg 204 (2007) 1188-1198
33. Qaseem A., Snow V., Fitteman N., et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med 144 (2006) 575-580
34. Bluman L.G., Masca L., Newman N., et al. Preoperative smoking habits and postoperative pulmonary complications. Chest 113 (1998) 883-889
35. Moller A.M., Maaloe R., and Pedersen T. Postoperative intensive care admittance: the role of tobacco smoking. Acta Anaesthesiol Scand 45 (2001) 345-348
36. Nakagawa M., Tanaka H., Tsukuma H., et al. Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest 120 (2001) 705-710
37. Warner M.A., Offord K.P., Warner M.E., et al. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc 64 (1989) 609-616
38. Rodgers A., Walker N., Schug S., et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from an overview of randomized trials. BMJ 321 (2000) 1493-1504
39. Khan M.A., and Hussain S.F. Pre-operative pulmonary evaluation. J Ayub Med Coll Abbottabad 17 (2005) 82-86
40. Ferrer M., Torsten T.B., Torres A., et al. Effect of nasogastric tube size on gastroesophageal reflux and microaspiration in intubated patients. Ann Intern Med 130 (1999) 991-994
41. Holzapfel L., Chevert S., Madinier G., et al. Influence of long-term oro- or nasotracheal intubation on nosocomial maxillary sinusitis and pneumonia: results of a prospective, randomized clinical trial. Crit Care Med 8 (1993) 1132-1138
42. Magne N., Marcy P.Y., Foa C., et al. Comparison between nasogastric tube feeding and percutaneous fluoroscopic gastrostomy tube feeding in advanced head and neck cancer patients. Eur Arch Otorhinolaryngol 258 (2001) 89-92
43. Dodek P., Keenan S., Cook D., et al. Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med 141 (2004) 305-313
44. van Nieuwenhoven C.A., Vandenbroucke-Graul S.C., van Tiel F.H., et al. Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: a randomized study. Crit Care Med 34 (2006) 396-402
45. de Jonge E., Schultz M.J., Spanjaard L., et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomized controlled trial. Lancet 362 (2003) 1011-1016
46. Ross A., and Crumpler J. The impact of an evidence-based practice education program on the role of oral care in the prevention of ventilator-associated pneumonia. Intensive Crit Care Nurs 23 (2007) 132-136
47. Segers P., Speekenbrink R.G.H., Ubbink D.T., et al. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 296 (2006) 2460-2466
48. Chlebicki M.P., and Safdar N. Topical chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 35 (2007) 595-602
49. Kollef M.H. Role of selective digestive tract decontamination on mortality and respiratory tract infections: a meta-analysis. Chest 105 (1994) 1101-1108
50. Cook D., Heyland D., Griffith D., et al. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation; Canadian Critical Care Trials Group. Crit Care Med 27 (1999) 2812-2817
51. Cook D., Griffith L.E., Walter S.D., et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 5 (2001) 368-375
52. Cook D., Guyhatt G., Marshall J., et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 338 (1998) 791-797
53. Ramirez P., Ferrer M., and Torres A. Prevention measures for ventilator-associated pneumonia: a new focus on the endotracheal tube. Curr Opin Infect Dis 20 (2007) 190-197
54. Holzapfel L., Chastang C., Demingeon G., et al. A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia. Am J Respir Crit Care Med 159 (1999) 695-701
55. Salord F., Gaussorgues P., Marti-Flich J., et al. Nosocomial maxillary sinusitis during mechanical ventilation: a prospective comparison of orotracheal versus the nasotracheal route for intubation. Intensive Care Med 16 (1990) 390-393
56. Kollef M.H., Skubas N.J., and Sundt T.M. A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. Chest 116 (1999) 1339-1346
57. Lorente L., Lecuona M., Jiménez A., et al. Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. Am J Respir Crit Care Med 176 (2007) 1079-1083
58. Dezfulian C., Shojania K., Collard H.R., et al. Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med 118 (2005) 11-18
59. Niël-Weise B.S., Snoeren R.I.M.M., and van den Broed D.J. Policies for endotracheal suctioning of patients receiving mechanical ventilation: a systematic review of randomized controlled trials. Infect Control Hosp Epidemiol 28 (2007) 178-184
60. Combes P., Fauvage B., and Oleyer C. Nosocomial pneumonia in mechanically ventilated patients, a prospective randomized evaluation of the stericath closed suctioning system. Intensive Care Med 26 (2000) 878-882
61. Lorente M., Lecuona M., Martin M.M., et al. Ventilator-associated pneumonia using a closed versus open tracheal suction system. Crit Care Med 33 (2005) 115-119
62. Topeli A., Harmanci A., Cetinkaya Y., et al. Comparison of the effect of closed versus open endotracheal suction systems on the development of ventilator-associated pneumonia. J Hosp Infect 58 (2004) 14-19
63. Gastmeier P., and Geffers C. Prevention of ventilator-associated pneumonia: Analysis of studies published since 2004. J Hosp Infect 67 (2007) 1-8
64. Kollef M.H., Shapiro S.D., Fraser V.J., et al. Mechanical ventilation with and without 7-day circuit changes, a randomized controlled trial. Ann Intern Med 123 (1995) 168-174
65. Dreyfuss D., Djedaini K., Weber P., et al. Prospective study of nosocomial pneumonia and of patient and circuit colonization during mechanical ventilation with circuit changes every 48 hours versus no change. Am Rev Respir Dis 143 (1991) 738-743
66. Long M.N., Wickstrom G., Grimes A., et al. Prospective, randomized study of ventilator-associated pneumonia in patients with one versus three ventilator circuit changes per week. Infect Control Hosp Epidemiol 17 (1996) 14-19
67. Safdar N., Crnich C.J., and Redlich U. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care 50 (2005) 725-739
68. Dreyfuss D., Djedaini K., Gros I., et al. Mechanical ventilation with heated humidifiers or heat and moisture exchangers: effects on patient colonization and incidence of nosocomial pneumonia. Am J Respir Crit Care Med 151 (1995) 986-992
69. Lacherade J.C., Auburtin M., Cerf C., et al. Impact of humidification systems of ventilator-associated pneumonia. Am J Respir Crit Care Med 172 (2005) 1276-1282
70. Boots R., George N., Faoagali J., et al. Double-heater-wire circuits and head- and moisture exchanger and the risk of ventilator-associated pneumonia. Crit Care Med 34 (2006) 687-693
71. Kress J.P., As P., O'Connor M.F., et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342 (2000) 1461-1477
72. Schweickert W.D., Gehlbach B.K., Pohlman A.S., et al. Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med 32 (2004) 1272-1276
73. Marelich G.P., Murin S., Battistella F., et al. Protocol weaning of mechanical ventilation in medical and surgical patients by respiratory care practitioners and nurses: effect on weaning time and incidence of ventilator-associated pneumonia. Chest 118 (2000) 459-467
74. Girard T.D., Kress J.P., Fuchs B.D., et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (awakening and breathing controlled trial): a randomized controlled trial. Lancet 371 (2008) 126-134
75. Smetana G.W., Lawrence V.A., and Cornell J.E. Preoperative pulmonary risk stratification for noncardiothoracic surgery: a systematic review for the American College of Physicians. Ann Intern Med 144 (2006) 581-595
76. Freitas E.R.F.S., Soares B.G.O., Cardoso J.R., et al. Incentive spirometry for preventing pulmonary complications after coronary artery bypass graft. [Review]. The Cochrane Collaboration (2007) 1-18
77. Criteria for defining nosocomial pneumonia. NHSN 1 (2005) 1-9
78. Andrews C.P., Coalson J.J., Smith J.D., et al. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest 80 (1981) 248-254
79. Bell R.C., Coalson J.J., Smith J.D., et al. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 99 (1983) 293-298
80. Niederman M.S. The clinical diagnosis of ventilator-associated pneumonia. Respir Care 50 (2005) 788-796
81. Pugin J., Auckenthaler R., Mill N., et al. Diagnosis of ventilator-associated pneumonia by batcteriologic analysis of bronchoscopic and non-bronchoscopic "blind" bronchoalveolar lavage. Am Rev Respir Dis 143 (1991) 1121-1129
82. Luyt C.E., Chastre J., Fagon J.Y., et al. Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med 30 (2004) 844-852
83. Fagon J. Hospital acquired pneumonia: diagnostic strategies: lessons from clinical trials. Infect Dis Clin North Am 17 (2003) 717-726
84. Singh N., Rogers P., Atwood C., et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive-care unit: a proposed solution for indiscriminate antibiotic use. Am J Respir Crit Care Med 162 (2000) 505-511
85. Mueller E.W., Croce M.A., Boucher B.A., et al. Repeat bronchoalveolar lavage to guide antibiotic duration for ventilator-associated pneumonia. J Trauma 63 (2007) 1329-1337
86. Lode H., Raffenberg M., Erbes R., et al. Nosocomial pneumonia: epidemiology, pathogenesis, diagnosis, treatment and prevention. Curr Opin Infect Dis 13 (2000) 377-384
87. Heyland D.K., Cook D.J., Marshall J., et al. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Chest 115 (1999) 1076-1084
88. Timsit J.F., Cheval C., Gachot B., et al. Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia. Intensive Care Med 27 (2001) 640-647
89. Ruiz M., Torres A., Ewig S., et al. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med 162 (2000) 119-125
90. The Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 355 (2006) 2619-2630
91. Fagon J.Y., Chastre J., Wolff M., et al. Invasive and non-invasive strategies for management of suspected ventilator-associated pneumonia: a randomized controlled trial. Ann Intern Med 132 (2000) 621-630
92. Croce M.A., Fabian T.C., Schurr M.J., et al. Using bronchoalveolar lavage to distinguish nosocomial pneumonia from systemic inflammatory response syndrome: a prospective analysis. J Trauma 39 (1995) 1134-1139
93. Croce M.A., Fabian T.C., Waddle-Smith L., et al. Utility of Gram's stain and efficacy of quantitative culture for posttraumatic pneumonia: a prospective study. Ann Surg 227 (1998) 743-751
94. Shorr A.F., Sherner J.H., Jackson W.L., et al. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 33 (2005) 46-53
95. Ioanas M., Ferrer M., Cavalcanti M., et al. Causes and predictors of non-response to treatment of intensive care unit-acquired pneumonia. Crit Care Med 32 (2004) 938-945
96. Mueller E.W., Hanes S.D., Croce M.A., et al. Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients. J Trauma 58 (2005) 94-101
97. Garcia J.C.P., Filho O.F.F., Grion C.M.C., et al. Impact of the implementation of a therapeutic guideline on the treatment of nosocomial pneumonia acquired in the intensive care unit of a university hospital. J Bras Pneumol 33 (2007) 175-184
98. Kashuba A.D.M., Nafziger A.N., Drusano G.L., et al. Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria. Antimicrobial Agents Chemother 43 (1999) 623-629
99. Steinkraus G., White R., and Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Am Cult 60 (2007) 788-794
100. Wang G., Hindler J.F., Ward K.W., et al. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol 44 (2006) 3883-3886
101. Adler J. The use of daptomycin for Staphylococcus aureus infections in critical care medicine. Crit Care Clin 24 (2008) 349-363
102. French G.L. Bactericidal agents in the treatment of MRSA infections- the potential role of daptomycin. J Antimicrob Chemother 58 (2006) 1107-1117
103. Shorr A.F., Combes A., Kollef M.H., et al. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy. Crit Care Med 34 (2006) 700-706
104. Michalopoulos A., Fotakis D., Virtzili S., et al. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant gram negative bacteria: a prospective study. Respir Med 102 (2008) 407-412
105. Rios F.G., Luna C.M., Maskin B., et al. Ventilator-associated pneumonia due to colistin susceptible-only microorganisms. Eur Respir J 30 (2007) 307-313
106. Linden P.K., and Paterson D.L. Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia. Clin Infect Dis 43 Suppl 2 (2006) 89-94
107. Pieracci F.M., and Barie P.S. Strategies in the prevention and management of ventilator-associated pneumonia. The American Surgeon 73 (2007) 419-432
108. Lynch J.P. Combination antibiotic therapy is appropriate for nosocomial pneumonia in the intensive care unit. Semin Respir Infect 8 (1993) 268-284
109. Arbo M.D., and Snydman D.R. Monotherapy is appropriate for nosocomial pneumonia in the intensive care unit. Semin Respir Infect 8 (1993) 259-267
110. Croce M.A., Fabian T.C., Stewart R.M., et al. Empiric monotherapy versus combination therapy of nosocomial pneumonia in trauma patients. J Trauma 35 (1993) 303-309
111. Ibrahim E.H., Ward S., Sherman G., et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 29 (2001) 1109-1115
112. Heyland D.K., Dodek P., Muscedere J., et al. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med 36 (2008) 737-744
113. Garnacho-Montero J., Sa-Borges M., Sole-Violan J., et al. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med 35 (2007) 1888-1895
114. Chastre J., Wolff M., Fagon J., et al. Comparison of 8 vs. 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. JAMA 290 (2003) 2588-2598
115. Trouillet J.L., Chastre J., Vuagnat A., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157 (1998) 531-539
116. Harris A.D., McGregor J.C., Johnson J.A., et al. Risk factors for colonization with extended spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerging Infect Dis 13 (2007) 1144-1149
117. Alvarez-Lerma F., Alvarez B., Luque P., et al. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective, observational study. Crit Care 10 (2006) R78-R88
118. Rello J., Vidaur L., Sandiumenge A., et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 32 (2004) 2183-2190
119. Giantsou E., Liratzopoulos N., Efraimidou E., et al. De-escalation therapy rates are significantly higher by bronchalveolar lavage than by tracheal aspiration. Intensive Care Med 33 (2007) 1533-1540
120. Salahuddin N., Zafar A., Sukhyani L., et al. Reducing ventilator-associated pneumonia rates through a staff education programme. J Hosp Infect 57 (2004) 223-227
121. The Johns Hopkins Hospital Antibiotic Management Program, Treatment Recommendations for Adult Inpatients, 2007.
122. Cocanour C.S., Peninger M., Domonoske B.D., et al. Decreasing ventilator-associated pneumonia in a trauma ICU. J Trauma 61 (2006) 122-130
123. Tolentino-DelosReyes A.F., Ruppert S.D., and Shiao S.P.K. Evidence-based practice: use of the ventilator bundle to prevent ventilator-associated pneumonia. Am J Crit Care 16 (2007) 20-27
124. Holzapfel L., Chevert S., Madinier G., et al. Influence of long-term oro- or nasotracheal intubation on nosocomial maxillary sinusitis and pneumonia: results of a prospective, randomized clinical trial. Crit Care Med 21 (1993) 1132-1138